Tri-lab COVID-19 Consortium, Desautels, TA, Arrildt, KT, Zemla, AT, Lau, EY, Zhu, F, Ricci, D, Cronin, S, Zost, SJ, Binshtein, E, Scheaffer, SM, Dadonaite, B, Petersen, BK, Engdahl, TB, Chen, E, Handal, LS, Hall, L, Goforth, JW, Vashchenko, D, Nguyen, S, Weilhammer, DR, Lo, JKY, Rubinfeld, B, Saada, EA, Weisenberger, T, Lee, TH, Whitener, B
, Case, JB, Ladd, A, Silva, MS, Haluska, RM, Grzesiak, EA, Earnhart, CG, Hopkins, S, Bates, TW
, Thackray, LB, Segelke, BW, Lyon, EZA, Anderson, PS, Avila-Herrera, A, Bennett, WF, Bourguet, FA, Chen, JC, Coleman, MA, Collette, NM, Davis, A, Vannest, BD, Fong, EJ, Gilmore, S, Goncalves, AR, Hall, SB, Harmon, B, He, W, Hoang-Phou, SA, Landajuela, M, Laurence, TA, Lee, TH, Da Silva, FL, Liu, C, Mundhenk, TN, Mohagheghi, MV, McIlroy, PR, Pham, LTM, Sanchez, JC, Sinha, A, Solomon, EA, Watkins, N, Yang, J, Ye, C, Zhang, B, Lillo, AM, Sundaram, S, Bloom, JD
, Diamond, MS, Crowe, JE, Carnahan, RH & Faissol, DM 2024, '
Computationally restoring the potency of a clinical antibody against Omicron',
Nature, vol. 629, no. 8013, pp. 878-885.
https://doi.org/10.1038/s41586-024-07385-1